ARCHIVES

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

Graalman Objects To Criticism On Contract Competition

April 22, 1977

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

March 13, 1981

Smoking Intensity and Markers Predict Cancer Aggressiveness

January 25, 2013

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005

Antman, Clanton begin work at NCI.

December 5, 2003